• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Final Research Report

Reprogramming and re-differentiation of invariant NKT cells for pancreatic cancer immunotherapy

Research Project

  • PDF
Project/Area Number 26462078
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Digestive surgery
Research InstitutionNational Cancer Center Japan

Principal Investigator

UEMURA Yasushi  国立研究開発法人国立がん研究センター, 先端医療開発センター, ユニット長 (40364781)

Project Period (FY) 2014-04-01 – 2017-03-31
Keywords外科 / 膵臓 / がん / 免疫
Outline of Final Research Achievements

Vα24 invariant natural killer T (iNKT) cells are a subset of T lymphocytes implicated in the regulation of broad immune responses. Reduced iNKT cell numbers and function have been observed in many patients with cancer. To recover these numbers, we reprogrammed human iNKT cells to pluripotency and then re-differentiated them into regenerated iNKT cells in vitro through an IL-2/IL-15-based optimized cytokine combination. The re-differentiated iNKT cells showed proliferation and IFN-γ production in response to α-galactosylceramide, induced dendritic cell maturation and downstream activation of cytotoxic T lymphocytes, and exhibited NKG2D- and DNAM-1-mediated NK cell-like cytotoxicity against cancer cell lines.
The immunological features of re-differentiated iNKT cells and their unlimited availability from induced pluripotent stem cells offer a potentially effective immunotherapy against pancreatic cancer.

Free Research Field

腫瘍免疫学

URL: 

Published: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi